RECORDATI: CONTINUING THE JOURNEY OF PROFITABLE GROWTH

September 2023

AGENDA

Recordati today, strategy and value proposition

  • Recordati today
  • Strategy and 2023-2025 Financial projections

Two core businesses

  • Specialty & Primary Care
  • Rare diseases

2023 first half results and FY 2023 guidance

AGENDA

Recordati today, strategy and value proposition

  • Recordati today
  • Strategy and 2023-2025 Financial projections

Two core businesses

  • Specialty & Primary Care
  • Rare diseases

2023 first half results and FY 2023 guidance

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Recordati Industria Chimica e Farmaceutica S.p.A. published this content on 08 September 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 September 2023 08:01:06 UTC.